Wave Life Sciences, Inc. (WVE)
4.86
+0.16
(+3.40%)
USD |
NASDAQ |
Sep 04, 16:00
4.855
0.00 (0.00%)
After-Hours: 20:00
Wave Life Sciences Total Assets (Quarterly) : 558.32M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 558.32M |
| March 31, 2026 | 583.54M |
| December 31, 2025 | 638.50M |
| September 30, 2025 | 241.38M |
| June 30, 2025 | 252.36M |
| March 31, 2025 | 288.34M |
| December 31, 2024 | 352.21M |
| September 30, 2024 | 358.50M |
| June 30, 2024 | 208.82M |
| March 31, 2024 | 235.27M |
| December 31, 2023 | 274.95M |
| September 30, 2023 | 199.92M |
| June 30, 2023 | 229.98M |
| March 31, 2023 | 267.27M |
| December 31, 2022 | 146.39M |
| September 30, 2022 | 181.51M |
| June 30, 2022 | 213.32M |
| March 31, 2022 | 167.36M |
| December 31, 2021 | 207.01M |
| September 30, 2021 | 200.51M |
| June 30, 2021 | 206.41M |
| March 31, 2021 | 242.65M |
| Date | Value |
|---|---|
| December 31, 2020 | 279.24M |
| September 30, 2020 | 310.06M |
| June 30, 2020 | 203.95M |
| March 31, 2020 | 238.57M |
| December 31, 2019 | 284.25M |
| September 30, 2019 | 347.21M |
| June 30, 2019 | 385.55M |
| March 31, 2019 | 430.61M |
| December 31, 2018 | 295.94M |
| September 30, 2018 | 324.58M |
| June 30, 2018 | 353.74M |
| March 31, 2018 | 150.42M |
| December 31, 2017 | 181.84M |
| September 30, 2017 | 202.09M |
| June 30, 2017 | 226.43M |
| March 31, 2017 | 151.51M |
| December 31, 2016 | 164.81M |
| September 30, 2016 | 179.97M |
| June 30, 2016 | 190.34M |
| March 31, 2016 | 158.52M |
| December 31, 2015 | 165.42M |
| September 30, 2015 | 71.00M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 103.90M |
| CorMedix, Inc. | 904.05M |
| Eloxx Pharmaceuticals, Inc. | 63.39M |
| Cannabis Global, Inc. | 0.885M |
| Breakthrough Chemistry, Inc. | 1.300M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 104.80M |
| Shareholders Equity (Quarterly) | 453.52M |
| Debt to Equity Ratio | 0.0961 |
| Current Ratio | 9.987 |
| Net Debt Paydown Yield | -0.36% |